Tag: MERS Treatment
Phase I Clinical Trials Underway for First MERS Treatment
SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical development company, announced today that Phase I Clinical Trials are underway for its human antibody treatment (SAB-301)...